Medicine, Hematology Oncology Division

Grants

Grants per year 1995 2007 2008 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2028

• 477 Active
• 1104 Finished

Grants per year

Search results

• Research project

  Prot# 3129K3-101-WW: A Phase 1/2 Study of CMC-544 Administered in Combination with Rituximab in Subjects With Follicular or Diffuse Large B-Cell Non-Hodgkin's Lymphoma

  Winter, J. N.

  Wyeth

  11/17/06 → 9/1/11

  Project: Research project

• Prot# FavId-04: Phase II Trial of Rituxan® plus FavId? (Tumor-Specific Idiotype-KLH) and GM-CSF Immunotherapy in Patients with Grade 1 or 2 Follicular B-Cell Lymphoma

  Winter, J. N.

  Favrille, Inc.

  2/25/03 → 1/1/11

  Project: Research project

• Prot# NU 99H11: A Phase I Trial Combining IDEC-Y2B8 and High-Dose Beam Chemotherapy with Hematopoietic Progenitor Cell Transplant in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (Study No. 131-I01)

  Winter, J. N.

  IDEC Pharmaceuticals Corporation

  6/16/00 → 1/1/11

  Project: Research project

• Interdisciplinary Palliative Care Education Program

  Paice, J.

  Rush University Medical Center, National Cancer Institute

  9/29/05 → 8/31/10

  Project: Research project

• Prot# 015-00: Phase I Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (MK-0683) (L-001079038) in Combination with Bortezomib in Patients With Advanced Multiple Myeloma

  Singhal, S.

  PRA Health Sciences, Merck & Co., Inc.

  4/11/06 → 4/11/09

  Project: Research project

• Prot#2011-002: Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients with Relapsed and Refractory Disease

  Singhal, S.

  ACT Oncology, LLC, Onyx Pharmaceuticals, Inc.

  11/18/11 → 11/18/17

  Project: Research project

• Prot# SG040-0004: A Phase II Study of SGN-40 (anti-huCD40 mAb) in Patients with Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)

  Winter, J. N.

  Seattle Genetics, Inc.

  4/27/07 → 12/1/11

  Project: Research project

• Prot# NU 10CC03: Cold Therapy to Prevent Paclitaxel-Induced Peripheral Neuropathy and Cutaneous Toxicity

  Paice, J. & Harden, R. N.

  Southwest Technologies, Inc.

  9/1/11 → 12/31/15

  Project: Research project

• End of Life Nursing Education through Graduate Programs

  Paice, J.

  City of Hope National Medical Center and Beckman Research Institute, National Cancer Institute

  7/1/02 → 6/30/07

  Project: Research project

• Prot# PX-171-003: An Open-Label, Single-Arm, Phase 2 Study of Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma

  Singhal, S.

  Proteolix, Inc.

  11/7/07 → 12/31/13

  Project: Research project

• Prot #CO-1686-019: TIGER-2: A Phase 2, Open-Label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-Directed TKI in Patients with Mutant EGFR Non-Small Cell Lung Cancer (NSCLC)

  Mohindra, N. A.

  Clovis Oncology, Inc.

  10/8/14 → 12/28/15

  Project: Research project

• TGF-Beta Antibody for Prostate Cancer: Role of ERK

  Lee, C. & Zhang, Q.

  U.S. Army Medical Research and Materiel Command

  6/15/09 → 6/14/13

  Project: Research project

• Prot# CZOL446E2352: A Prospective, Randomized, Dbl-Blind, Stratified, Placebo-Controlled, Multi-Center, 3-Arm Trial of the Continued Efficacy & Safety of Zometa(Every 4 Wks v Every 12 Wks v Placebo)in Ptnts w/Documented Bone Metastases from Bre

  Gradishar, W. J.

  Novartis Pharmaceuticals Corporation

  1/29/07 → 9/1/11

  Project: Research project

• NCI UC12N01 / NCI 9742

  Agulnik, M.

  University of Chicago, National Cancer Institute

  9/30/12 → 9/22/16

  Project: Research project

• SPORE in Breast Cancer: Project 6: Angiostatic Therapy for Breast Cancer: A Translational Study (Soff)

  Gradishar, W. J.

  National Cancer Institute

  9/30/00 → 8/31/06

  Project: Research project

• A Retrospective Clinical Trial to Determine Biomarkers for Disease Recurrence in Prostate Cancer Patients: A Tissue Microarray Approach

  Lee, C. & Zhang, Q.

  Illinois Department of Public Health

  3/16/08 → 3/15/09

  Project: Research project

• Novel Pain Assessment and Intervention Network (NoPAIN)

  Chang, C., Emanuel, L. L., Hauser, J. M., Liebovitz, D. M. & Paice, J.

  National Cancer Institute

  9/27/04 → 7/31/06

  Project: Research project

  • Pain Measurement 100%
  • Pain 80%
  • Clinical Decision Support Systems 77%
  • Geriatrics 75%
  • Pain Management 40%

• Prot #SCRX003-001: A Phase 1a/1b Dose Escalation and Expansion Study of Single-Agent SC-003 in Subjects with Platinum-Resistant/Refractory Ovarian Cancer

  Matei, D. E.

  Novella Clinical, LLC, AbbVie Stemcentrx LLC

  9/11/17 → 12/31/20

  Project: Research project

• Prot #MO39196: A Phase III, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination with Paclitaxel Compared with Placebo with Paclitaxel for Patients with Previously Untreated Inoperable Locall

  Gradishar, W. J.

  PRA Health Sciences, Genentech, Inc.

  11/15/17 → 11/30/21

  Project: Research project

• Prot #STU00206173: c-Met: A Potential Target for the Treatment of Advanced Ovarian Cancer

  Matei, D. E., Kocherginsky, M. & Shahabi, S.

  AbbVie Inc.

  12/1/17 → 12/31/21

  Project: Research project

  • Ovarian Neoplasms 100%
  • Drug Therapy 37%
  • Ovarian Epithelial Carcinoma 36%
  • Neoplasms 30%
  • Non-Small Cell Lung Carcinoma 28%

• Epigenetic Vulnerabilities of Ovarian Cancer Stem Cells

  Matei, D. E. & Peter, M. E.

  Indiana University-Purdue University Indianapolis, Ovarian Cancer Research Fund Alliance

  1/1/17 → 6/30/20

  Project: Research project

• 9th Annual Lynn Sage Breast Cancer Symposium

  Gradishar, W. J.

  Merck & Co., Inc.

  4/1/07 → 3/31/09

  Project: Research project

• 10th Annual Lynn Sage Breast Cancer Symposium

  Gradishar, W. J.

  Bristol-Myers Squibb Company

  6/1/08 → 5/31/09

  Project: Research project

• 9th Annual Lynn Sage Breast Cancer Symposium

  Gradishar, W. J.

  Eli Lilly and Company

  4/1/07 → 3/31/09

  Project: Research project

• Prot #201501057: NU WU15S01: A Phase II Study of Pazopanib as Front-Line Therapy in Patients with Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

  Agulnik, M.

  Washington University St. Louis, GlaxoSmithKline LLC

  4/12/16 → 4/12/22

  Project: Research project